Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BOCHET

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Hepatology (Baltimore, Md.)|August 2, 2001
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapyY Benhamou, V Di Martino, M Bochet, et al.
Journal of Clinical Microbiology|August 17, 1999
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virusV Thibault, Y Benhamou, C Seguret, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsY Benhamou, M Bochet, V Thibault, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Indinavir crystal deposits associated with tubulointerstitial nephropathyF Martinez, H Mommeja-Marin, L Estepa-Maurice, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc GroupY Benhamou, M Bochet, V Di Martino, et al.
Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Hepatology (Baltimore, Md.)|August 2, 2001
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapyY Benhamou, V Di Martino, M Bochet, et al.
Journal of Clinical Microbiology|August 17, 1999
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virusV Thibault, Y Benhamou, C Seguret, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsY Benhamou, M Bochet, V Thibault, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Indinavir crystal deposits associated with tubulointerstitial nephropathyF Martinez, H Mommeja-Marin, L Estepa-Maurice, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc GroupY Benhamou, M Bochet, V Di Martino, et al.
Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.
Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.
Pageof 2